Overview

Fluorometholone Study

Status:
NOT_YET_RECRUITING

Trial end date:
2030-12-31

Target enrollment:

Participant gender:

Summary

The investigators seek to determine whether adjunctive topical fluorometholone (FML) improves best-corrected visual acuity (BCVA) at 3 months in patients with bacterial corneal ulcers compared with standard topical antibiotic therapy alone.

Phase:

PHASE2

Details

Lead Sponsor:

Vishal Jhanji

Collaborator:

University of Pittsburgh Medical Center

Treatments:

Fluorometholone